Emerging Infectious Disease ISSN: 1080-6059

Neutralizing Antibodies after Infection with Dengue 1 Virus

Gustavo Kourí*

, Mayling Alvarez*, Rosmari Rodriguez-Roche*, Lídice Bernardo*, Tibaire Montes†, Susana Vazquez*, Luis Morier*, Angel Alvarez*, Ernest A Gould‡, Maria G. Guzman*

, and Scott B Halstead§

Author affiliations: *“Pedro Kourí” Tropical Medicine Institute, Havana, Cuba; †Instituto Medicina Tropical, Caracas, Venezuela; ‡Centre for Ecology and Hydrology, Oxford, United Kingdom; §Pediatric Dengue Vaccine Initiative, Bethesda, Maryland, USA;

Main Article

Figure

Log10 antibody (Ab) titers for human dengue virus type 1–immune serum samples collected in 1999 (89 samples) and 1981–1985 (50 samples, mean).

Figure. Log₁₀ antibody (Ab) titers for human dengue virus type 1–immune serum samples collected in 1999 (89 samples) and 1981–1985 (50 samples, mean).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.